https://healthylivingeurope.com/article/910389523-aquila-clouds-launches-uk-operations-to-redefine-cloud-and-ai-financial-control Healthy Living Europe en PressRelease 2026-05-06T07:15:00+00:00 Aquila Clouds Launches UK Operations to Redefine Cloud and AI Financial Control https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24626383-aquila-clouds-1996x1000.png https://healthylivingeurope.com/article/910723925-vogt-koyanagi-harada-syndrome-market-set-for-8-7-cagr-through-2033-persistence-market-research Healthy Living Europe en PressRelease 2026-05-06T06:58:07+00:00 Vogt-Koyanagi-Harada Syndrome Market Set for 8.7% CAGR Through 2033 | Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848655-vogt-koyanagi-harada-vkh-syn-1040x720.png https://healthylivingeurope.com/article/910722811-vitreous-detachment-treatment-market-to-reach-us-5-3-bn-by-2033-growing-at-4-5-cagr-persistence-market-research Healthy Living Europe en PressRelease 2026-05-06T06:18:08+00:00 Vitreous Detachment Treatment Market to Reach US$ 5.3 Bn by 2033, Growing at 4.5% CAGR: Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848649-vitreous-detachment-treatment-m-1040x720.png https://healthylivingeurope.com/article/910717885-chinese-top-3-pen-assembly-machine-manufacturers-in-2026-driving-global-precision-automation-innovation Healthy Living Europe en PressRelease 2026-05-06T05:48:11+00:00 Chinese Top 3 Pen Assembly Machine Manufacturers in 2026: Driving Global Precision Automation Innovation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848640-logo-for-paifeite-automation-800x800.png https://healthylivingeurope.com/article/910282649-keypedia-adds-mhra-data-bringing-uk-regulatory-intelligence-into-a-single-platform Healthy Living Europe en PressRelease 2026-05-06T01:00:00+00:00 KeyPedia Adds MHRA Data, Bringing UK Regulatory Intelligence Into a Single Platform https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847069-gks-mhra-1348x1256.png https://healthylivingeurope.com/article/910605809-at-global-forum-in-los-angeles-a-saudi-hospital-puts-cancer-scale-at-the-center-of-the-conversation Healthy Living Europe en PressRelease 2026-05-05T21:18:41+00:00 At Global Forum in Los Angeles, a Saudi Hospital Puts Cancer Scale at the Center of the Conversation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848344-cancer-3500x2199.jpeg https://healthylivingeurope.com/article/910595724-idox-ai-introduces-life-sciences-and-healthcare-edition-of-ai-powered-privacy-suite Healthy Living Europe en PressRelease 2026-05-05T20:27:37+00:00 iDox.ai Introduces Life Sciences and Healthcare Edition of AI-Powered Privacy Suite https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848290-idox-ai-1269x352.png https://healthylivingeurope.com/article/910567698-poultry-diagnostics-market-analysis-report-2026-major-trends-growth-factors-and-forecast-overview Healthy Living Europe en PressRelease 2026-05-05T18:34:08+00:00 Poultry Diagnostics Market Analysis Report 2026: Major Trends, Growth Factors, and Forecast Overview https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910568580-the-rabies-diagnostics-market-is-projected-to-grow-to-2-4-billion-by-2030-expanding-at-a-compound-growth-rate-of-6-7 Healthy Living Europe en PressRelease 2026-05-05T18:34:08+00:00 The Rabies Diagnostics Market is projected to grow to $2.4 billion by 2030, expanding at a compound growth rate of 6.7% https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910569340-the-spay-and-neuter-market-is-projected-to-grow-at-a-cagr-of-5-4-between-2026-and-2030-3-1-billion-revenue-by-2030 Healthy Living Europe en PressRelease 2026-05-05T18:34:08+00:00 The Spay and Neuter Market is projected to grow at a CAGR of 5.4% between 2026 and 2030, $3.1 billion revenue by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910566209-pet-mobility-aids-market-size-share-competitive-overview-and-trend-analysis-report Healthy Living Europe en PressRelease 2026-05-05T18:34:07+00:00 Pet Mobility Aids Market: Size, Share, Competitive Overview, and Trend Analysis Report https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910566971-industry-report-projects-pet-sitting-and-daycare-software-market-to-expand-at-a-6-7-cagr-until-2030 Healthy Living Europe en PressRelease 2026-05-05T18:34:07+00:00 Industry Report Projects Pet Sitting and Daycare Software Market to Expand at a 6.7% CAGR Until 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910565445-the-pet-funeral-services-market-is-expected-to-grow-at-a-cagr-of-10-8-between-2026-and-2030-reaching-3-billion-2030 Healthy Living Europe en PressRelease 2026-05-05T18:34:06+00:00 The Pet Funeral Services Market is expected to grow at a CAGR of 10.8% between 2026 and 2030, reaching $3 billion 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910564663-the-pet-diabetes-care-market-is-projected-to-grow-to-3-7-billion-by-2030-expanding-at-a-cagr-of-9-6 Healthy Living Europe en PressRelease 2026-05-05T18:34:05+00:00 The Pet Diabetes Care Market is projected to grow to $3.7 billion by 2030, expanding at a CAGR of 9.6% https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910448551-multiple-myeloma-treatment-market-set-for-robust-growth-reaching-us-14-6-bn-by-2033-persistence-market-research Healthy Living Europe en PressRelease 2026-05-05T18:00:00+00:00 Multiple Myeloma Treatment Market Set for Robust Growth, Reaching US$ 14.6 Bn by 2033 | Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847612-multiple-myeloma-treatment-mark-1040x720.png https://healthylivingeurope.com/article/910730182-immutrin-appoints-leading-cardiovascular-drug-development-expert-dr-robert-blaustein-as-chief-medical-officer-and-establishes-us-subsidiary Healthy Living Europe en PressRelease 2026-05-06T06:00:00+00:00 Immutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary https://ml-eu.globenewswire.com/media/b8f96d3c-b61d-4f73-8c17-929d628c2984/small/image-2immutrin-jpg.jpg https://healthylivingeurope.com/article/910730186-avacta-presents-new-comparisons-of-pre-cision-payload-release-vs-approved-adcs-and-ava6207-dual-payload-delivery-at-science-day-2026 Healthy Living Europe en PressRelease 2026-05-06T06:00:00+00:00 Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://healthylivingeurope.com/article/910565206-why-therapy-isn-t-working-fast-enough-and-what-s-replacing-it Healthy Living Europe en PressRelease 2026-05-05T17:48:27+00:00 Why Therapy Isn’t Working Fast Enough—And What’s Replacing It https://healthylivingeurope.com/article/910464953-ruminant-feed-antibiotics-market-report-2026-growth-drivers-key-trends-and-expansion-outlook-to-2030 Healthy Living Europe en PressRelease 2026-05-05T17:43:21+00:00 Ruminant Feed Antibiotics Market Report 2026: Growth Drivers, Key Trends, and Expansion Outlook to 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910465683-swine-artificial-insemination-market-2026-2030-revealing-growth-trends-and-recent-developments Healthy Living Europe en PressRelease 2026-05-05T17:43:21+00:00 Swine Artificial Insemination Market 2026-2030: Revealing Growth Trends and Recent Developments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910463485-the-poultry-feed-mycotoxin-binders-and-modifiers-market-is-projected-to-grow-to-4-billion-by-2030 Healthy Living Europe en PressRelease 2026-05-05T17:43:20+00:00 The Poultry Feed Mycotoxin Binders and Modifiers Market is projected to grow to $4 billion by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910461902-pet-oral-care-products-market-opportunities-share-trends-competitive-landscape-2030-forecast Healthy Living Europe en PressRelease 2026-05-05T17:43:17+00:00 Pet Oral Care Products Market: Opportunities, Share, Trends, Competitive Landscape & 2030 Forecast https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910460349-global-market-report-on-pet-diabetes-care-devices-2026-business-expansion-key-drivers-and-trends-through-2030 Healthy Living Europe en PressRelease 2026-05-05T17:43:15+00:00 Global Market Report on Pet Diabetes Care Devices 2026: Business Expansion, Key Drivers, and Trends Through 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910458375-pet-cancer-therapeutics-market-analysis-report-2026-major-trends-driving-factors-and-forecast-overview Healthy Living Europe en PressRelease 2026-05-05T17:43:14+00:00 Pet Cancer Therapeutics Market Analysis Report 2026: Major Trends, Driving Factors, and Forecast Overview https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910459221-the-pet-care-e-commerce-market-is-projected-to-grow-to-60-1-billion-by-2030 Healthy Living Europe en PressRelease 2026-05-05T17:43:14+00:00 The Pet Care E-commerce Market is Projected to Grow to $60.1 Billion by 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910457515-the-veterinary-monoclonal-antibody-health-market-is-to-grow-at-a-14-8-cagr-through-2030-industry-analysis Healthy Living Europe en PressRelease 2026-05-05T17:43:13+00:00 The Veterinary Monoclonal Antibody Health Market is to grow at a 14.8% CAGR through 2030: Industry Analysis https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910452207-the-feed-mycotoxin-binders-and-modifiers-market-is-projected-to-grow-to-3-9-billion-by-2030-expanding-at-a-7-cagr Healthy Living Europe en PressRelease 2026-05-05T17:43:12+00:00 The Feed Mycotoxin Binders and Modifiers Market is projected to grow to $3.9 billion by 2030, expanding at a 7% CAGR. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910452833-foot-and-mouth-disease-vaccine-market-to-grow-at-10-1-cagr-hitting-4-5b-by-2030 Healthy Living Europe en PressRelease 2026-05-05T17:43:12+00:00 Foot and Mouth Disease Vaccine Market to grow at 10.1% CAGR, hitting $4.5B by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910451677-feed-and-animal-nutrition-industry-analysis-report-2026-major-trends-growth-drivers-and-forecast-overview Healthy Living Europe en PressRelease 2026-05-05T17:43:11+00:00 Feed and Animal Nutrition Industry Analysis Report 2026: Major Trends, Growth Drivers, and Forecast Overview https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910470233-veterinary-disposables-market-analysis-of-opportunities-market-share-growth-competition-and-forecast-through-2030 Healthy Living Europe en PressRelease 2026-05-05T17:42:08+00:00 Veterinary Disposables Market: Analysis of Opportunities, Market Share, Growth, Competition, and Forecast through 2030 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910469614-veterinary-diagnostic-equipment-market-2026-2030-exploring-growth-trends-and-recent-developments Healthy Living Europe en PressRelease 2026-05-05T17:42:07+00:00 Veterinary Diagnostic Equipment Market 2026-2030: Exploring Growth Trends and Recent Developments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910451181-equine-healthcare-market-expected-to-expand-at-a-6-4-cagr-until-2030-industry-report Healthy Living Europe en PressRelease 2026-05-05T17:42:01+00:00 Equine Healthcare Market Expected to Expand at a 6.4% CAGR Until 2030: Industry Report https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910445692-animal-intestinal-health-market-to-grow-at-11-2-cagr-2026-2030-reaching-7-6b-by-2030 Healthy Living Europe en PressRelease 2026-05-05T17:41:57+00:00 Animal Intestinal Health Market to grow at 11.2% CAGR (2026–2030), reaching $7.6B by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910450604-market-size-share-competitive-landscape-and-trend-analysis-report-for-companion-animal-veterinary-vaccines Healthy Living Europe en PressRelease 2026-05-05T17:40:50+00:00 Market Size, Share, Competitive Landscape, and Trend Analysis Report for Companion Animal Veterinary Vaccines https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910449535-the-canine-arthritis-treatment-market-is-projected-to-grow-at-a-4-7-cagr-reaching-3-1-billion-by-2030 Healthy Living Europe en PressRelease 2026-05-05T17:40:49+00:00 The Canine Arthritis Treatment Market is projected to grow at a 4.7% CAGR, reaching $3.1 billion by 2030. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910448924-automatic-smart-pet-feeders-market-2026-key-trends-drivers-challenges-and-forecast-insights Healthy Living Europe en PressRelease 2026-05-05T17:40:47+00:00 Automatic & Smart Pet Feeders Market 2026: Key Trends, Drivers, Challenges, and Forecast Insights https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/786757-tbrc-1024x302.jpeg https://healthylivingeurope.com/article/910445861-cosmeceuticals-market-to-expand-at-4-1-cagr-through-2033-persistence-market-research Healthy Living Europe en PressRelease 2026-05-05T17:30:00+00:00 Cosmeceuticals Market to Expand at 4.1% CAGR Through 2033 | Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847606-cosmeceuticals-market-1040x720.png https://healthylivingeurope.com/article/910547325-top-1-seo-operator-behind-teladoc-s-pre-ipo-growth-launches-by-invitation-fractional-cmo-practice Healthy Living Europe en PressRelease 2026-05-05T17:10:03+00:00 Top 1% SEO Operator Behind Teladoc's Pre-IPO Growth Launches By-Invitation Fractional CMO Practice https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24848114-henry-hank-hugh-hernandez-fract-900x1115.png https://healthylivingeurope.com/article/910719259-philips-delivers-strong-order-intake-comparable-sales-growth-and-margin-expansion-in-q1-2026-outlook-reiterated Healthy Living Europe en PressRelease 2026-05-06T05:00:00+00:00 Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://healthylivingeurope.com/article/910696959-avalo-therapeutics-announces-pricing-of-375-million-public-offering Healthy Living Europe en PressRelease 2026-05-06T03:33:54+00:00 Avalo Therapeutics Announces Pricing of $375 Million Public Offering https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://healthylivingeurope.com/article/910696876-lbl-047-prioritized-for-clinical-development-in-sj-gren-s-disease-systemic-lupus-erythematosus-and-dermatomyositis Healthy Living Europe en PressRelease 2026-05-06T02:57:21+00:00 LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis https://ml.globenewswire.com/media/YjZkMjQxNjctYjA3Ni00YmZkLThkMGMtZDhmZTMzNGI3ZTMxLTEzMDgzODktMjAyNi0wNS0wNi1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://healthylivingeurope.com/article/910686158-writeupp-introduces-embedded-ai-medical-scribe-with-soap-dap-and-birp-note-generation-at-ca-40-per-user Healthy Living Europe en PressRelease 2026-05-06T02:45:54+00:00 WriteUpp Introduces Embedded AI Medical Scribe With SOAP, DAP and BIRP Note Generation at CA$40 Per User https://ml.globenewswire.com/media/a75e2abd-2872-4427-9104-2e700e6a8340/medium/writeupp-introduces-embedded-ai-medical-scribe-with-soap-dap.png https://healthylivingeurope.com/article/909725122-validsoft-launches-enhanced-voice-identity-platform-vip-to-secure-the-ai-voice-economy Healthy Living Europe en PressRelease 2026-05-05T14:15:00+00:00 ValidSoft Launches Enhanced Voice Identity Platform (VIP™) to Secure the AI Voice Economy https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24845843-validsoft-logo-no-tag-1800x1200.png https://healthylivingeurope.com/article/909211333-jeeva-unveils-new-logo-and-website-marking-its-evolution-into-ai-ready-clinical-os Healthy Living Europe en PressRelease 2026-05-05T14:00:00+00:00 Jeeva Unveils New Logo and Website, Marking Its Evolution into AI-Ready Clinical OS https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837528-jeeva-clinical-new-logo-3770x1160.png https://healthylivingeurope.com/article/689600161-dr-jason-mcmahon-provides-advanced-male-health-services-at-gentle-procedures-leinster Healthy Living Europe en PressRelease 2026-05-05T13:06:59+00:00 Dr. Jason McMahon Provides Advanced Male Health Services at Gentle Procedures Leinster https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847244-dr-mcmahon-1506x1062.png https://healthylivingeurope.com/article/910237823-west-shore-community-college-sets-new-standard-in-paramedic-training-with-eolife-x-integration Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 West Shore Community College sets new standard in Paramedic training with EOlife X integration https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846774-dan-yost-portrait-540x540.png https://healthylivingeurope.com/article/910661966-rapid-nutrition-enhances-investor-access-with-agentic-ai-driven-on-demand-communication-platform Healthy Living Europe en PressRelease 2026-05-06T00:27:06+00:00 Rapid Nutrition Enhances Investor Access with Agentic AI driven On-Demand Communication Platform https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://healthylivingeurope.com/article/910300241-how-strokes-that-trigger-psychiatric-symptoms-are-guiding-new-approaches-to-brain-stimulation-therapy Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 How strokes that trigger psychiatric symptoms are guiding new approaches to brain stimulation therapy https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847164-causal-network-mapping-can-be-c-1786x998.png https://healthylivingeurope.com/article/910236957-business-reporter-achieving-full-stack-sovereignty Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Business Reporter: Achieving full-stack sovereignty https://healthylivingeurope.com/article/910237340-solaris-endovascular-receives-fda-breakthrough-device-designation-for-solaris-de-a-new-drug-eluting-covered-stent Healthy Living Europe en PressRelease 2026-05-05T11:00:35+00:00 Solaris Endovascular Receives FDA Breakthrough Device Designation for Solaris DE™, a new Drug-Eluting Covered Stent https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24460542-de-stent-with-drug-on-edges-620x397.jpeg https://healthylivingeurope.com/article/910278259-unobravo-mindex-2026-l-italia-ancora-carente-sull-educazione-emotiva-solo-1-italiano-su-4-alfabetizzato-alle-emozioni Healthy Living Europe en PressRelease 2026-05-05T10:30:00+00:00 Unobravo MINDex 2026 - L’Italia ancora carente sull'educazione emotiva: solo 1 italiano su 4 alfabetizzato alle emozioni https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847036-unbravo1-1920x1080.png https://healthylivingeurope.com/article/910636745-isothrive-reports-highly-statistically-significant-phase-2-data-for-mhs-1031-in-nerd-patients-at-ddw-2026 Healthy Living Europe en PressRelease 2026-05-05T22:16:13+00:00 ISOThrive Reports Highly Statistically Significant Phase 2 Data for MHS-1031 in NERD Patients at DDW 2026 https://ml.globenewswire.com/media/bbf9967c-a7fb-4fa6-b7e7-3cab0c0479b9/medium/cover-image.jpg https://healthylivingeurope.com/article/910624511-biomea-fusion-announces-poster-presentations-of-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions Healthy Living Europe en PressRelease 2026-05-05T21:50:41+00:00 Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions https://ml.globenewswire.com/media/d2f051eb-da8d-4233-9093-8ff1579d035f/small/biomea-fusion-logo-rgb-rev2-email-png.png https://healthylivingeurope.com/article/910624458-mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Healthy Living Europe en PressRelease 2026-05-05T21:34:32+00:00 Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://healthylivingeurope.com/article/910624423-epik-biosciences-launches-to-pioneer-ketamine-powered-psychedelic-therapies-to-transform-treatment-of-mental-health-pain-and-addiction Healthy Living Europe en PressRelease 2026-05-05T21:20:00+00:00 EPIK Biosciences Launches to Pioneer Ketamine-Powered Psychedelic Therapies to Transform Treatment of Mental Health, Pain, and Addiction https://ml.globenewswire.com/media/3ffb3db0-76c3-46ee-84b6-368a18fbeefc/small/epik-png.png https://healthylivingeurope.com/article/910612410-aura-biosciences-announces-closing-of-299-million-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares Healthy Living Europe en PressRelease 2026-05-05T21:15:00+00:00 Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://healthylivingeurope.com/article/909319374-lifebit-launches-security-tower-to-enforce-security-controls-and-safeguard-sensitive-data-at-scale Healthy Living Europe en PressRelease 2026-05-05T09:00:00+00:00 Lifebit Launches Security Tower to Enforce Security Controls and Safeguard Sensitive Data at Scale https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24844561-lifebit-security-tower-launch-d-2400x1256.png https://healthylivingeurope.com/article/910351683-biomed-industries-inc-advances-dual-track-obesity-therapy-strategy-with-near-term-revenue-and-na-931-phase-3-launch Healthy Living Europe en PressRelease 2026-05-05T09:00:00+00:00 Biomed Industries, Inc. Advances Dual-Track Obesity Therapy Strategy with Near-Term Revenue and NA-931 Phase 3 Launch https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/20763193-biomed-pipeline-900x513.png https://healthylivingeurope.com/article/910382040-one-year-later-tark-thermal-solutions-builds-on-its-legacy-as-thermal-issues-gain-strategic-importance-across-industries Healthy Living Europe en PressRelease 2026-05-05T09:00:00+00:00 One Year Later Tark Thermal Solutions Builds on Its Legacy as Thermal Issues Gain Strategic Importance Across Industries https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847474-lt3257-pr-image-900x600.png https://healthylivingeurope.com/article/910330107-auxilius-joins-veeva-product-partner-program-to-deliver-a-clearer-view-of-clinical-trial-costs Healthy Living Europe en PressRelease 2026-05-05T08:45:00+00:00 Auxilius Joins Veeva Product Partner Program to Deliver a Clearer View of Clinical Trial Costs https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847351-veeva-product-partner-501x348.png https://healthylivingeurope.com/article/910460930-vistatec-life-sciences-and-global-regulatory-writing-consulting-accelerate-global-regulatory-submissions Healthy Living Europe en PressRelease 2026-05-05T08:37:40+00:00 Vistatec Life Sciences and Global Regulatory Writing & Consulting Accelerate Global Regulatory Submissions https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847636-global-1200x627.png https://healthylivingeurope.com/article/910225557-ceo-insight-s-investors-guide-examines-evolving-investment-strategies-across-global-financial-markets Healthy Living Europe en PressRelease 2026-05-05T08:30:00+00:00 CEO Insight’s Investors Guide Examines Evolving Investment Strategies Across Global Financial Markets https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846814-jamie-harrison-1310x1508.png https://healthylivingeurope.com/article/910611978-steris-announces-dividend-of-0-63-per-share Healthy Living Europe en PressRelease 2026-05-05T20:30:00+00:00 STERIS Announces Dividend of $0.63 per share https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://healthylivingeurope.com/article/910612071-theriva-biologics-reports-first-quarter-2026-operational-highlights-and-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:30:00+00:00 Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://healthylivingeurope.com/article/910612085-fda-expands-market-access-authorizes-new-ends-products Healthy Living Europe en PressRelease 2026-05-05T20:27:48+00:00 FDA Expands Market Access, Authorizes New ENDS Products https://ml.globenewswire.com/media/YjBiNDNiOTUtOGFkYi00NDg0LTlhYmMtYzJjNWJlNjIxNmY2LTUwMDE1NDE1NC0yMDI2LTA1LTA1LWVu/tiny/FDA.png https://healthylivingeurope.com/article/910612052-pacira-biosciences-mails-letter-to-stockholders Healthy Living Europe en PressRelease 2026-05-05T20:20:00+00:00 Pacira BioSciences Mails Letter to Stockholders https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://healthylivingeurope.com/article/910599747-longeveron-to-report-2026-first-quarter-financial-results-and-host-conference-call-on-may-13-2026 Healthy Living Europe en PressRelease 2026-05-05T20:15:00+00:00 Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026 https://ml.globenewswire.com/media/a6d6e61c-2a7d-4b22-954b-04b9841fbc38/small/longeveron-logo-jpg.jpg https://healthylivingeurope.com/article/910599971-sienna-reports-first-quarter-2026-financial-results-and-continues-platform-expansion Healthy Living Europe en PressRelease 2026-05-05T20:15:00+00:00 Sienna Reports First Quarter 2026 Financial Results and Continues Platform Expansion https://ml.globenewswire.com/media/ac969f39-0111-4903-8faa-0cdee524eb4e/small/sienna-logo-rgb-jpg.jpg https://healthylivingeurope.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Healthy Living Europe en PressRelease 2026-05-05T20:15:00+00:00 Cytokinetics Announces Proposed Public Offering of Common Stock https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://healthylivingeurope.com/article/910599138-onkure-therapeutics-reports-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 OnKure Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b01f7b95-9b60-4b2b-8515-fe0cae183fff/small/onkure-logo-jpg.jpg https://healthylivingeurope.com/article/910599159-sana-biotechnology-to-present-at-the-bofa-securities-2026-healthcare-conference Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg https://healthylivingeurope.com/article/910599164-spero-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-13-2026 Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/aad6f25c-1793-4870-a611-84ea3f25fed3/small/spero-logo-jpg.jpg https://healthylivingeurope.com/article/910599178-korro-to-participate-in-upcoming-investor-conferences Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Korro to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://healthylivingeurope.com/article/910599236-alamar-biosciences-to-participate-in-bofa-securities-2026-healthcare-conference Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/9394cf1d-76c7-4cf9-8ed3-cafcc57c9a84/small/alamardroplogo-4c-png.png https://healthylivingeurope.com/article/910599247-trevi-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://healthylivingeurope.com/article/910599249-adaptive-biotechnologies-reports-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Adaptive Biotechnologies Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg https://healthylivingeurope.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://healthylivingeurope.com/article/910599357-myriad-genetics-reports-first-quarter-2026-financial-results-reiterates-2026-financial-guidance-reflecting-ongoing-progress-in-the-cancer-care Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://healthylivingeurope.com/article/910599397-iridex-to-report-first-quarter-2026-financial-results-on-may-19-2026 Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 https://ml.globenewswire.com/media/2bb80159-a920-428b-aa69-c2f32e3038c9/small/iridex-corporate-logo-horizontal-rgb-m02-jpg.jpg https://healthylivingeurope.com/article/910599618-amwell-announces-results-for-first-quarter-2026 Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Amwell® Announces Results for First Quarter 2026 https://ml.globenewswire.com/media/ff1989f5-0a6a-4e00-99dc-cb29a818aca5/small/amwell-logo-blue-2023-v02-rgb-2-png.png https://healthylivingeurope.com/article/910599661-avalo-therapeutics-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://healthylivingeurope.com/article/910599743-innovage-announces-financial-results-for-the-fiscal-third-quarter-ended-march-31-2026 Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/a1b976fe-053f-43be-b43c-532393a7f314/small/inn-logotag-rgb-jpg.jpg https://healthylivingeurope.com/article/910599766-standard-biotools-reports-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Standard BioTools Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/122934c3-b763-4386-89d1-3047d0704c17/small/sbt-new-august-2022-logo.png https://healthylivingeurope.com/article/910599869-relay-therapeutics-reports-first-quarter-2026-financial-results-and-corporate-updates Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://healthylivingeurope.com/article/910600015-supernus-announces-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Supernus Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg https://healthylivingeurope.com/article/910600051-lemaitre-q1-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 LeMaitre Q1 2026 Financial Results https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://healthylivingeurope.com/article/910600067-verrica-pharmaceuticals-announces-upcoming-presentation-of-phase-2-data-highlighting-the-potential-abscopal-effects-of-vp-315-in-the-treatment-of Healthy Living Europe en PressRelease 2026-05-05T20:05:00+00:00 Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting  https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://healthylivingeurope.com/article/910599241-carlsmed-reports-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Carlsmed® Reports First Quarter 2026 Financial Results  https://ml.globenewswire.com/media/ee16eff2-e0d6-40ca-95c5-4dd84bb4cc5f/small/carlsmed-png.png https://healthylivingeurope.com/article/910599255-dianthus-therapeutics-highlights-recent-business-achievements-and-reports-q1-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results https://ml.globenewswire.com/media/c9002285-2240-4dab-aced-77296f86a3fa/small/dianthus-logo-primary-full-color-cmyk-png.png https://healthylivingeurope.com/article/910599363-monte-rosa-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://healthylivingeurope.com/article/910599377-avalyn-to-present-patient-centered-research-on-ap01-delivery-and-supportive-care-experiences-at-american-thoracic-society-2026-international Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://healthylivingeurope.com/article/910599422-praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://healthylivingeurope.com/article/910599496-ligand-to-participate-in-may-investor-conferences Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Ligand to Participate in May Investor Conferences https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://healthylivingeurope.com/article/910599599-ultragenyx-reports-first-quarter-2026-financial-results-and-corporate-update Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://healthylivingeurope.com/article/910599621-dentsply-sirona-reports-first-quarter-2026-results Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Dentsply Sirona Reports First Quarter 2026 Results https://ml.globenewswire.com/media/91e36dfa-44e3-4905-a186-3a988bd67ab8/small/dentsply-sirona-grey-80-black-rgb-jpg.JPG https://healthylivingeurope.com/article/910599629-avalo-therapeutics-achieves-positive-topline-results-in-phase-2-lotus-trial-of-abdakibart-avtx-009-in-moderate-to-severe-hidradenitis-suppurativa Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://healthylivingeurope.com/article/910599881-hyperion-defi-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://healthylivingeurope.com/article/910599936-healthequity-announces-first-quarter-earnings-release-date-and-investor-conference-schedule Healthy Living Europe en PressRelease 2026-05-05T20:01:00+00:00 HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule https://ml.globenewswire.com/media/30a1510d-03b1-4356-b38d-e9f75f1ec797/small/healthequitylogo-purple-2020-jpg.jpg https://healthylivingeurope.com/article/910599226-acumen-pharmaceuticals-to-report-first-quarter-financial-results-on-may-12-2026 Healthy Living Europe en PressRelease 2026-05-05T20:00:00+00:00 Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://healthylivingeurope.com/article/910599338-inmune-bio-and-anthony-nolan-announce-strategic-expansion-of-cordstrom-msc-platform-collaboration-to-target-rdeb-oncology-and-inflammatory-diseases Healthy Living Europe en PressRelease 2026-05-05T20:00:00+00:00 INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://healthylivingeurope.com/article/910587066-context-by-fulcra-dynamics-launches-updated-version-2-4-7-now-with-the-capacity-for-groups Healthy Living Europe en PressRelease 2026-05-05T19:22:00+00:00 Context, by Fulcra Dynamics, Launches Updated Version 2.4.7 - Now With the Capacity for Groups https://pressranger.s3.us-west-1.amazonaws.com/3254028/active_tab.png https://healthylivingeurope.com/article/910587060-neuvasq-presents-data-showcasing-promising-novel-multispecific-gpr124-targeting-antibodies-for-blood-retina-barrier-restoration-at-arvo-2026 Healthy Living Europe en PressRelease 2026-05-05T19:15:00+00:00 Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026 https://ml.globenewswire.com/media/758fbb1f-ac3c-4f37-ba02-64c0f59beff0/small/neuvasq-logo-png-png.png https://healthylivingeurope.com/article/910444471-3d-printed-surgical-models-market-to-reach-us-2-422-4-mn-by-2033-persistence-market-research Healthy Living Europe en PressRelease 2026-05-05T07:02:22+00:00 3D Printed Surgical Models Market to Reach US$ 2,422.4 Mn by 2033 | Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847602-3d-printed-surgical-models-mark-1040x720.png https://healthylivingeurope.com/article/910441244-ai-based-clinical-trials-solution-providers-market-grows-at-22-1-cagr-through-2033-persistence-market-research Healthy Living Europe en PressRelease 2026-05-05T07:02:15+00:00 AI-Based Clinical Trials Solution Providers Market Grows at 22.1% CAGR Through 2033 | Persistence Market Research https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847598-ai-based-clinical-trials-soluti-1040x720.png https://healthylivingeurope.com/article/910311408-aker-biomarine-showcases-integrated-health-solutions-at-vitafoods-europe-2026 Healthy Living Europe en PressRelease 2026-05-05T07:00:00+00:00 Aker BioMarine Showcases Integrated Health Solutions at Vitafoods Europe 2026 https://healthylivingeurope.com/article/910576181-sk-pharmteco-obtient-la-validation-de-la-sbti-pour-ses-objectifs-scientifiques-de-neutralit-carbone-horizon-2040 Healthy Living Europe en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco obtient la validation de la SBTi pour ses objectifs scientifiques de neutralité carbone à horizon 2040 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://healthylivingeurope.com/article/910576183-sk-pharmteco-erh-lt-sbti-validierung-f-r-wissenschaftsbasierte-netto-null-ziele-bis-2040 Healthy Living Europe en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco erhält SBTi-Validierung für wissenschaftsbasierte Netto-Null-Ziele bis 2040 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://healthylivingeurope.com/article/910576185-sk-pharmteco-2040-sbti Healthy Living Europe en PressRelease 2026-05-05T18:31:06+00:00 SK pharmteco, 2040년 넷제로 과학 기반 목표에 대한 글로벌 기후변화 대응 이니셔티브 (SBTi) 검증 획득 https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://healthylivingeurope.com/article/910576128-the-association-of-american-physicians-and-surgeons-files-in-the-u-s-supreme-court-in-opposition-to-mifepristone-abortion-by-mail Healthy Living Europe en PressRelease 2026-05-05T18:15:52+00:00 The Association of American Physicians and Surgeons Files in the U.S. Supreme Court in Opposition to Mifepristone Abortion-by-Mail https://ml.globenewswire.com/media/NThiZDE0ODctMDBhNC00N2UzLTkzZmMtNDUwYzc2ZTU0MjkzLTEwMzM1MTctMjAyNi0wNS0wNS1lbg==/tiny/Association-of-American-Physic.png https://healthylivingeurope.com/article/910565807-mesa-laboratories-inc-to-announce-fourth-quarter-and-full-fiscal-year-results-on-may-27-2026 Healthy Living Europe en PressRelease 2026-05-05T17:39:00+00:00 Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026 https://ml.globenewswire.com/media/ff66b401-9246-47b9-accc-2f553d346c5c/small/mesalogo-jpg.jpg https://healthylivingeurope.com/article/910565759-hantavirus-cluster-linked-to-cruise-ship-highlights-ongoing-zoonotic-risk-and-the-need-for-vigilance Healthy Living Europe en PressRelease 2026-05-05T17:20:00+00:00 Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://healthylivingeurope.com/article/910565666-ergodyne-mips-bring-another-head-protection-first-to-worksites Healthy Living Europe en PressRelease 2026-05-05T17:15:00+00:00 Ergodyne + Mips Bring Another Head Protection First to Worksites https://ml.globenewswire.com/media/NGEwMDhhNTMtYmMwNC00ODBmLWJiMGItMmMzNjU3MWQ4MjdlLTExODg4MTAtMjAyNi0wNS0wNS1lbg==/tiny/Ergodyne.png https://healthylivingeurope.com/article/910252219-microplastic-burden-in-the-human-brain-linked-to-stroke-and-dementia-apheresis-emerging-as-the-first-plausible-removal Healthy Living Europe en PressRelease 2026-05-05T05:00:00+00:00 Microplastic burden in the human brain linked to stroke and dementia: apheresis emerging as the first plausible removal https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846856-human-microplastic-burden-visu-2048x1741.jpeg https://healthylivingeurope.com/article/910565583-smith-nephew-drives-progress-in-chronic-wound-care-with-allevyn-complete-care-dressing-and-renasys-edge-tnpwt-set-to-launch-at-ewma-2026 Healthy Living Europe en PressRelease 2026-05-05T17:00:00+00:00 Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026 https://ml-eu.globenewswire.com/media/8512c693-36e3-49c5-9341-0e33875d614d/small/s-n-logo-jpg.jpg https://healthylivingeurope.com/article/910565607-scilex-holding-company-announces-its-subsidiaries-acea-therapeutics-inc-and-acea-pharma-inc-entered-into-a-definitive-agreement-with-phoenix Healthy Living Europe en PressRelease 2026-05-05T17:00:00+00:00 Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://healthylivingeurope.com/article/910555990-american-nurses-association-calls-for-nurse-led-guardrails-on-artificial-intelligence-in-healthcare Healthy Living Europe en PressRelease 2026-05-05T16:46:15+00:00 American Nurses Association Calls for Nurse-Led Guardrails on Artificial Intelligence in Healthcare https://ml.globenewswire.com/media/ZmJhMWViYzAtNWRmOS00MDI4LThjMGEtNGFiODlhNzc2ZjZjLTUwMDE2MTk2Mi0yMDI2LTA1LTA1LWVu/tiny/American-Nurses-Enterprise.png https://healthylivingeurope.com/article/910545481-valneva-to-report-first-quarter-2026-consolidated-financial-results-on-may-13-2026 Healthy Living Europe en PressRelease 2026-05-05T15:45:00+00:00 Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg https://healthylivingeurope.com/article/910545482-valneva-publiera-ses-r-sultats-financiers-consolid-s-du-premier-semestre-le-13-mai-2026 Healthy Living Europe en PressRelease 2026-05-05T15:45:00+00:00 Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026 https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/ https://healthylivingeurope.com/article/910545526-allsup-named-usa-today-s-top-workplace-third-year-in-a-row Healthy Living Europe en PressRelease 2026-05-05T15:27:44+00:00 Allsup Named USA Today’s Top Workplace Third Year In A Row https://ml.globenewswire.com/media/OTVmNmRkNjctYjAzMC00Y2M3LTg2OTktODg4ZmQ5NjYxOTYxLTEwOTcwODEtMjAyNi0wNS0wNS1lbg==/tiny/Allsup.png https://healthylivingeurope.com/article/910545507-correction-genembryomics-and-genomic-prediction-launch-xgen-pgt-x Healthy Living Europe en PressRelease 2026-05-05T15:08:38+00:00 CORRECTION: GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™ https://ml.globenewswire.com/media/ODM4NWIzMDItOGZhNy00ZTgyLWI5YTctNzE1NWI3MTk3MDU0LTEzMjMxNzktMjAyNi0wNS0wNS1lbg==/tiny/Genomic-Prediction.png https://healthylivingeurope.com/article/910545505-wellspan-health-opens-carlisle-hospital-expanding-emergency-care-in-a-growing-cumberland-county-corridor Healthy Living Europe en PressRelease 2026-05-05T15:07:16+00:00 WellSpan Health opens Carlisle hospital, expanding emergency care in a growing Cumberland County corridor https://ml.globenewswire.com/media/ZjI3MjljNTgtODgzMi00MGQ3LWJhMTQtZWFhNjVmMWZhZTRmLTEyMjE1MzQtMjAyNi0wNS0wNS1lbg==/tiny/WellSpan-Health.png https://healthylivingeurope.com/article/910536173-canadian-soccer-standout-cloey-uddenberg-and-team-physician-dr-kevin-asem-join-lung-health-foundation-s-national-push-to-keep-kids-with-asthma-in-the Healthy Living Europe en PressRelease 2026-05-05T15:00:00+00:00 Canadian Soccer Standout Cloey Uddenberg and Team Physician Dr. Kevin Asem Join Lung Health Foundation’s National Push to Keep Kids with Asthma in the Game https://ml.globenewswire.com/media/8463bfc8-e43b-49db-bf75-f2e28ae429c6/medium/play-prepared-ambassadors.jpg https://healthylivingeurope.com/article/910536165-atos-and-cna-strengthen-long-term-strategic-partnership-through-new-multi-year-infrastructure-services-agreement Healthy Living Europe en PressRelease 2026-05-05T14:49:42+00:00 Atos and CNA strengthen long-term strategic partnership through new multi-year infrastructure services agreement https://ml.globenewswire.com/media/3eacc37c-6163-4d11-95aa-944fca92da46/small/atos-logo-blue-rgb-png.png https://healthylivingeurope.com/article/910536118-the-matcha-tokyo-brings-premium-japanese-matcha-culture-to-toronto-s-ossington-strip-with-first-canadian-location-opening-may-16 Healthy Living Europe en PressRelease 2026-05-05T14:45:27+00:00 The Matcha Tokyo Brings Premium Japanese Matcha Culture to Toronto’s Ossington Strip with First Canadian Location Opening May 16 https://ml.globenewswire.com/media/Y2FiOWM5NDQtOTdkNy00ODEzLTlhN2UtZGEyZGUzMDMwZmI3LTUwMDE2MTk4NS0yMDI2LTA1LTA1LWVu/tiny/The-Matcha-Tokyo.png https://healthylivingeurope.com/article/910535873-global-sleep-apnea-devices-market-projected-to-exceed-usd-11-61-billion-by-2032-marketsandmarkets Healthy Living Europe en PressRelease 2026-05-05T14:45:00+00:00 Global Sleep Apnea Devices Market Projected to Exceed USD 11.61 Billion by 2032 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://healthylivingeurope.com/article/910536062-your-medicare-roadmap-what-to-know-before-you-turn-65 Healthy Living Europe en PressRelease 2026-05-05T14:27:56+00:00 Your Medicare Roadmap: What to Know Before You Turn 65 https://ml.globenewswire.com/media/e29e0200-7282-4635-af4f-01abe250557e/small/feature-impact-editorlogin-logo2026-png.png https://healthylivingeurope.com/article/910526322-new-aua-census-shows-shifts-in-urology-workforce-practice-workloads-and-ai-use Healthy Living Europe en PressRelease 2026-05-05T14:02:00+00:00 New AUA Census Shows Shifts in Urology Workforce, Practice Workloads and AI Use https://ml.globenewswire.com/media/YWMwNjQ1Y2UtNjlmNy00MTUxLTkxMzQtYjBiNzFiNGJhNDQ5LTEyNzYxOTAtMjAyNi0wNS0wNS1lbg==/tiny/American-Urological-Associatio.png https://healthylivingeurope.com/article/910526620-lighthouse-autism-center-opening-new-autism-therapy-center-in-council-bluffs-iowa Healthy Living Europe en PressRelease 2026-05-05T14:00:29+00:00 Lighthouse Autism Center Opening New Autism Therapy Center in Council Bluffs, Iowa https://ml.globenewswire.com/media/e432b138-98bf-4971-921d-61bc5ac70fa7/small/lighthouse-primary-png.png https://healthylivingeurope.com/article/910526308-bayridge-counselling-centres-and-no-fear-counselling-corp-merge-under-ch-y-qtel-wellness-to-form-canada-s-largest-first-nation-s-owned-mental-health Healthy Living Europe en PressRelease 2026-05-05T14:00:00+00:00 Bayridge Counselling Centres and No Fear Counselling Corp Merge Under Ch’íyáqtel Wellness to Form Canada’s Largest First Nation’s Owned Mental Health Network https://ml.globenewswire.com/media/77b1c55c-807c-4a32-9598-7cafb1ac92c3/small/cw-new-logo-1-png.png https://healthylivingeurope.com/article/910526359-aafa-leads-group-of-patients-clinicians-asking-congress-to-protect-programs-that-help-people-with-asthma-and-allergies Healthy Living Europe en PressRelease 2026-05-05T14:00:00+00:00 AAFA Leads Group of Patients, Clinicians Asking Congress to Protect Programs that Help People with Asthma and Allergies https://ml.globenewswire.com/media/MDUxY2I5MTctZWI2Yy00NGExLThiMDEtNWM5ZjJkZDVhMWMzLTExMDE5NjItMjAyNi0wNS0wNS1lbg==/tiny/Asthma-and-Allergy-Foundation-.png https://healthylivingeurope.com/article/910526516-lighthouse-autism-center-opening-new-autism-therapy-center-in-mount-pleasant-iowa Healthy Living Europe en PressRelease 2026-05-05T13:48:22+00:00 Lighthouse Autism Center Opening New Autism Therapy Center in Mount Pleasant, Iowa https://ml.globenewswire.com/media/e432b138-98bf-4971-921d-61bc5ac70fa7/small/lighthouse-primary-png.png https://healthylivingeurope.com/article/910526307-featol-introduces-back-brace-support-belt-for-everyday-lower-back-support Healthy Living Europe en PressRelease 2026-05-05T13:32:00+00:00 FEATOL Introduces Back Brace Support Belt for Everyday Lower Back Support https://ml.globenewswire.com/media/b68de2c9-db44-424f-ba79-1b88cf5f3338/medium/featol-back-brace-rear-view-with-breathable-lightweight-mesh.png https://healthylivingeurope.com/article/910517765-alpha-tau-announces-upcoming-podium-presentation-at-the-ahns-12th-international-conference-on-head-and-neck-cancer-showcasing-study-results-of-alpha Healthy Living Europe en PressRelease 2026-05-05T13:14:32+00:00 Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://healthylivingeurope.com/article/910516832-sk-pharmteco-achieves-sbti-validation-for-2040-net-zero-science-based-targets Healthy Living Europe en PressRelease 2026-05-05T13:03:00+00:00 SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://healthylivingeurope.com/article/910516701-chemed-corporation-to-present-at-the-bank-of-america-securities-health-care-conference-2026 Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026 https://ml.globenewswire.com/media/1ab951c0-8d76-40e0-bc65-ebeaa1731e66/small/chemed-corp-logo-600x400-jpg.jpg https://healthylivingeurope.com/article/910516733-karl-jacob-s-fix-your-insulin-hits-1-amazon-best-seller-in-diabetes-category-launches-limited-time-0-99-reader-promotion Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 Karl Jacob's "Fix Your Insulin" Hits #1 Amazon Best Seller in Diabetes Category, Launches Limited-Time $0.99 Reader Promotion https://pressranger.s3.us-west-1.amazonaws.com/3242430/The-Insulin-Fix_Cover-6.jpg https://healthylivingeurope.com/article/910516841-heartsciences-signs-first-saas-revenues-agreement-following-full-launch-of-myovista-insights Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ https://ml.globenewswire.com/media/800a6aae-74f3-42bb-9199-5e169ed9b881/small/heartsciences-png.png https://healthylivingeurope.com/article/910517024-precision-optics-announces-receipt-of-3-5-million-follow-on-production-order-for-single-use-ophthalmic-program Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 Precision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic Program https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://healthylivingeurope.com/article/910517058-bicycle-health-expands-leadership-team-to-increase-access-to-evidence-based-opioid-use-disorder-care Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 Bicycle Health Expands Leadership Team to Increase Access to Evidence-Based Opioid Use Disorder Care https://ml.globenewswire.com/media/ba03cedc-3d11-4aa5-b226-cb5784309493/small/copy-of-bhvirtualcarelogo-black-2x-jpg.jpg https://healthylivingeurope.com/article/910517073-maps-state-of-colorado-partner-to-deliver-free-harm-reduction-training-for-first-responders Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 MAPS & State of Colorado Partner to Deliver Free Harm Reduction Training for First Responders https://ml.globenewswire.com/media/4f774750-4742-4818-be22-116e2b2085b1/small/maps-logo-2021-primary-horizontal-white-background-1200x486.jpg https://healthylivingeurope.com/article/910517086-femasys-enables-ob-gyns-to-deliver-first-line-fertility-treatment-with-initial-commercial-use-of-femaseed-complete Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://healthylivingeurope.com/article/910517333-health-canada-authorizes-north-america-s-first-hepatitis-b-rapid-test-biolytical-s-istatis-hepatitis-b-surface-antigen-test Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 Health Canada Authorizes North America’s First Hepatitis B Rapid Test, bioLytical’s iStatis Hepatitis B Surface Antigen Test https://ml.globenewswire.com/media/8c4f4c4f-8565-4ee5-9842-ca4d0dcf67fb/medium/istatis-hepatitis-b-surface-antigen-test.jpg https://healthylivingeurope.com/article/910517373-biosphere-awarded-9-million-u-s-army-contract-to-develop-on-demand-nutrition-production-system-for-warfighters Healthy Living Europe en PressRelease 2026-05-05T13:00:00+00:00 Biosphere Awarded $9 Million U.S. Army Contract to Develop On-Demand Nutrition Production System for Warfighters https://ml.globenewswire.com/media/e816f42d-d6f4-462f-a3af-65eb8d733841/small/logo1-png.png https://healthylivingeurope.com/article/910516816-cellution-biologics-celebrates-expansion-of-u-s-headquarters-in-roswell-georgia Healthy Living Europe en PressRelease 2026-05-05T12:55:00+00:00 Cellution Biologics Celebrates Expansion of U.S. Headquarters in Roswell, Georgia https://ml.globenewswire.com/media/25f5b530-a1f5-4314-a4b9-9d2a0ec2a934/small/cb-logo-colorfs-png.png https://healthylivingeurope.com/article/910517494-clearmind-medicine-announces-filing-of-european-patent-application-for-novel-psychedelic-compounds-for-the-treatment-of-ptsd Healthy Living Europe en PressRelease 2026-05-05T12:50:00+00:00 Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://healthylivingeurope.com/article/910517538-clene-announces-7-million-underwritten-offering-of-common-stock Healthy Living Europe en PressRelease 2026-05-05T12:45:00+00:00 Clene Announces $7 Million Underwritten Offering of Common Stock https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://healthylivingeurope.com/article/910507674-ocugen-provides-business-update-with-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T12:32:54+00:00 Ocugen Provides Business Update with First Quarter 2026 Financial Results https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://healthylivingeurope.com/article/910506917-sab-bio-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-may-12-2026-08-30-am-et Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png https://healthylivingeurope.com/article/910507058-ss-innovations-surpasses-10-500-surgeries-performed-with-the-ssi-mantra-surgical-robotic-system Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System https://ml.globenewswire.com/media/cef267e0-040f-4889-a706-cc4d0ae49e55/small/new-logo-april-23-2025-png.png https://healthylivingeurope.com/article/910507118-achieve-life-sciences-to-announce-first-quarter-2026-financial-results-and-host-conference-call-and-webcast-on-may-12-2026 Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026 https://ml.globenewswire.com/media/1026e030-275c-4391-8f9a-65c5c1ec7b88/small/achieve-logo-717x800px-2-1-jpg.jpg https://healthylivingeurope.com/article/910507145-sofwave-medical-reports-first-quarter-fiscal-2026-financial-results-and-business-highlights Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Sofwave Medical Reports First Quarter Fiscal 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/9fbd88c7-2eaf-45c3-b046-2d055fe94a07/small/download-png.png https://healthylivingeurope.com/article/910507153-disc-medicine-reports-first-quarter-2026-financial-results-and-provides-business-update Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://healthylivingeurope.com/article/910507252-palisade-bio-reports-additional-phase-1a-b-data-demonstrating-colon-targeted-exposure-and-sustained-ic90-coverage-supporting-once-daily-dosing-in Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis https://ml.globenewswire.com/media/0beaede8-1c7c-4f77-84a7-b1efd54c343c/small/logo-png.png https://healthylivingeurope.com/article/910507258-cormedix-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-a-corporate-update-on-may-14-2026 Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026 https://ml.globenewswire.com/media/a14d732c-3f66-4a3c-96bb-7fc8ba5797bb/small/crmd-logo-jpg.jpg https://healthylivingeurope.com/article/910507278-fate-therapeutics-selected-for-u-s-fda-chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-to-support-manufacturing Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819 https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://healthylivingeurope.com/article/910507452-oragenics-activates-second-site-in-phase-iia-clinical-trial-of-onp-002-for-concussion-and-mild-traumatic-brain-injury Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury. https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://healthylivingeurope.com/article/910507457-profusa-initiates-board-led-process-to-evaluate-strategic-alternatives-and-maximize-shareholder-value Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value https://ml.globenewswire.com/media/a8137a61-b858-48da-9e47-1f1bf8f6ddba/small/profusa-logo-jpg.jpg https://healthylivingeurope.com/article/910507458-imunon-to-hold-first-quarter-2026-financial-results-and-business-update-conference-call-on-tuesday-may-12-2026 Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026 https://ml.globenewswire.com/media/acf78e45-a45b-456b-93e3-0e39f2122826/small/logo-png.png https://healthylivingeurope.com/article/910507620-microbot-medical-s-liberty-endovascular-robotic-system-is-now-adopted-by-multiple-accounts-across-key-territories-including-two-access-pvi-pivotal Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://healthylivingeurope.com/article/910507662-fibrobiologics-ceo-issues-letter-to-shareholders Healthy Living Europe en PressRelease 2026-05-05T12:30:00+00:00 FibroBiologics CEO Issues Letter to Shareholders https://ml.globenewswire.com/media/f3ebedd0-66f2-4e20-b298-4b52bbb42404/medium/pete-o-heeron.jpg https://healthylivingeurope.com/article/910507657-ocugen-inc-announces-pricing-of-115-million-of-6-75-convertible-senior-notes Healthy Living Europe en PressRelease 2026-05-05T12:12:21+00:00 Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://healthylivingeurope.com/article/910507636-blood-banking-devices-market-size-to-surpass-usd-9-08-bn-by-2034-driven-by-rising-number-of-blood-banks-globally Healthy Living Europe en PressRelease 2026-05-05T12:06:12+00:00 Blood Banking Devices Market Size to Surpass USD 9.08 BN by 2034, Driven by Rising Number of Blood Banks Globally https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://healthylivingeurope.com/article/910507192-noom-names-power-of-habit-author-charles-duhigg-as-advisor-releases-new-research-linking-glp-1-success-to-habit-formation Healthy Living Europe en PressRelease 2026-05-05T12:02:00+00:00 Noom Names “Power of Habit” Author Charles Duhigg as Advisor, Releases New Research Linking GLP-1 Success to Habit Formation https://ml.globenewswire.com/media/6b8c0d7a-2154-4867-82d3-f7e88a9793ee/medium/noom-psychosocial-report-findings.jpg https://healthylivingeurope.com/article/910506877-allarity-therapeutics-advances-stenoparib-toward-pivotal-development-with-phase-3-manufacturing-campaign Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Allarity Therapeutics Advances Stenoparib Toward Pivotal Development with Phase 3 Manufacturing Campaign https://ml-eu.globenewswire.com/media/fd1e4c64-f0cf-40e0-a0c9-0be0d6dce544/small/allarity-full-color-rgb-2023jun07-png.png https://healthylivingeurope.com/article/910506884-spyre-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://healthylivingeurope.com/article/910506912-nu-tek-biosciences-presents-data-driven-approach-to-animal-cell-culture-optimization-at-esact-2026 Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Nu-Tek BioSciences Presents Data-Driven Approach to Animal Cell Culture Optimization at ESACT 2026 https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://healthylivingeurope.com/article/910506922-nu-tek-biosciences-pr-sentiert-auf-der-esact-2026-einen-datengest-tzten-ansatz-zur-optimierung-der-tierischen-zellkultur Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Nu-Tek BioSciences präsentiert auf der ESACT 2026 einen datengestützten Ansatz zur Optimierung der tierischen Zellkultur https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://healthylivingeurope.com/article/910506928-nu-tek-biosciences-pr-sente-une-approche-fond-e-sur-les-donn-es-pour-l-optimisation-de-la-culture-de-cellules-animales-lors-de-l-esact-2026 Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Nu-Tek BioSciences présente une approche fondée sur les données pour l’optimisation de la culture de cellules animales lors de l’ESACT 2026 https://ml.globenewswire.com/media/348e95f7-f41b-461f-94c6-c663f05170e8/small/nutek-logo-rgb-4x-jpg.jpg https://healthylivingeurope.com/article/910506939-healthverity-to-acquire-symphony-health-uniting-clinical-data-and-commercial-analytics-to-accelerate-breakthroughs-across-the-healthcare-ecosystem Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem https://ml.globenewswire.com/media/e2010eff-0993-44c1-a40d-9f0237268a35/medium/healthverity.jpg https://healthylivingeurope.com/article/910506952-septerna-to-present-at-bank-of-america-securities-health-care-conference Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Septerna to Present at Bank of America Securities Health Care Conference https://ml.globenewswire.com/media/8c635733-2794-456f-9bc4-3b53908acba9/small/septernalogo-black-10x-jpg.jpg https://healthylivingeurope.com/article/910507011-transplants-org-launches-as-centralized-education-and-navigation-platform-for-organ-and-stem-cell-transplant-patients Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Transplants.org Launches as Centralized Education and Navigation Platform for Organ and Stem Cell Transplant Patients https://ml.globenewswire.com/media/1d980326-1679-4adb-bd02-7e4358b841ce/small/transplants-org-logo-color-jpg.jpg https://healthylivingeurope.com/article/910507047-clene-to-present-at-upcoming-may-conferences Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Clene to Present at Upcoming May Conferences https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://healthylivingeurope.com/article/910507089-geron-plans-to-present-at-upcoming-investor-conferences Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Geron Plans to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://healthylivingeurope.com/article/910507095-minerva-neurosciences-provides-first-quarter-2026-financial-results-and-business-updates Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/69e604cb-25b6-4235-ae9a-17c25cc158b9/small/minerva-logo.jpg https://healthylivingeurope.com/article/910507163-cg-oncology-to-present-at-upcoming-investor-conferences-in-may Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 CG Oncology to Present at Upcoming Investor Conferences in May https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://healthylivingeurope.com/article/910507196-corbus-pharmaceuticals-to-host-in-person-and-virtual-kol-event-at-asco-2026 Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026 https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://healthylivingeurope.com/article/910507205-zentalis-pharmaceuticals-announces-first-patient-dosed-in-aspenova-phase-3-trial-of-azenosertib-in-patients-with-cyclin-e1-positive-platinum-resistant Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://healthylivingeurope.com/article/910507214-picard-medical-announces-pricing-of-5-million-offering Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Picard Medical Announces Pricing of $5 Million Offering https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://healthylivingeurope.com/article/910507244-filana-therapeutics-presents-tsc-related-epilepsy-program-at-eilat-xviii Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII https://ml.globenewswire.com/media/984a6554-2b2a-4cf7-9a32-72ac808d52ac/small/filana400-png.png https://healthylivingeurope.com/article/910507247-madrigal-adds-clinical-stage-sirna-asset-targeting-pnpla3-to-its-mash-pipeline Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://healthylivingeurope.com/article/910507268-pathai-and-a-c-camargo-cancer-center-announce-cooperation-to-expand-digital-pathology-with-ai-in-brazil-via-sus Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 PathAI and A.C.Camargo Cancer Center Announce Cooperation to Expand Digital Pathology with AI in Brazil via SUS https://ml.globenewswire.com/media/ab2bfc12-ae80-47c6-9345-a98783489ed7/small/pathai-logo-standard-png.png https://healthylivingeurope.com/article/910507406-cogent-biosciences-reports-recent-business-highlights-and-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://healthylivingeurope.com/article/910507408-verrica-pharmaceuticals-to-report-first-quarter-2026-financial-results-and-provide-a-corporate-update-on-may-12-2026 Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026 https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://healthylivingeurope.com/article/910507428-bionano-announces-a-56-increase-in-publications-describing-the-utility-of-ogm-in-rare-diseases-in-q1-2026-vs-q1-2025 Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://healthylivingeurope.com/article/910507624-mineralys-therapeutics-to-participate-in-the-bank-of-america-securities-health-care-conference Healthy Living Europe en PressRelease 2026-05-05T12:00:00+00:00 Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://healthylivingeurope.com/article/910507632-latest-digestive-health-supplements-market-size-expected-to-reach-usd-25-86-billion-by-2034-with-6-10-cagr-driven-by-rising-geriatric-population Healthy Living Europe en PressRelease 2026-05-05T11:59:13+00:00 [Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://healthylivingeurope.com/article/910507208-neuronetics-reports-first-quarter-2026-financial-and-operating-results Healthy Living Europe en PressRelease 2026-05-05T11:50:00+00:00 Neuronetics Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png https://healthylivingeurope.com/article/910497076-discure-technologies-appoints-dr-ray-baker-to-its-board-of-directors Healthy Living Europe en PressRelease 2026-05-05T11:35:00+00:00 Discure Technologies Appoints Dr. Ray Baker to its Board of Directors https://ml.globenewswire.com/media/eb02cf21-747a-4619-8cb2-b3929c46ae7e/small/descure-technologies-logo-png.PNG https://healthylivingeurope.com/article/910497087-kura-oncology-to-report-first-quarter-2026-financial-results Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Kura Oncology to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://healthylivingeurope.com/article/910497096-intellia-therapeutics-to-participate-in-upcoming-investor-conferences Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Intellia Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://healthylivingeurope.com/article/910497121-compass-therapeutics-reports-2026-first-quarter-financial-results-and-provides-corporate-update Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update  https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://healthylivingeurope.com/article/910497160-bridgebio-to-present-primary-results-from-the-phase-3-calibrate-trial-at-2026-ece Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://healthylivingeurope.com/article/910497222-surgery-partners-inc-announces-first-quarter-2026-results-reaffirms-full-year-2026-guidance Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance https://ml.globenewswire.com/media/d0188456-e6d3-48f9-8479-b40422f00e4c/small/surgerypartnerslinear-1-jpg.jpg https://healthylivingeurope.com/article/910497278-tris-pharma-appoints-jim-potenziano-ph-d-as-chief-science-and-development-officer Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Tris Pharma Appoints Jim Potenziano, Ph.D. as Chief Science and Development Officer https://ml.globenewswire.com/media/2ab6667c-5742-4090-afb8-459cd811c92e/small/logo-png.png https://healthylivingeurope.com/article/910497407-cytokinetics-announces-positive-topline-results-from-acacia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-non-obstructive Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy https://ml.globenewswire.com/media/adcf634e-a2a7-4cdf-98b3-ca658eab1b35/medium/figure-1-assessments-of-kccq-and-pvo2.png https://healthylivingeurope.com/article/910497479-nuvectis-pharma-inc-reports-first-quarter-2026-financial-results-and-business-highlights Healthy Living Europe en PressRelease 2026-05-05T11:30:00+00:00 Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/aceda01c-bc94-4579-88fa-c0294406b49f/small/nuvectispharma-logos-final-full-color-png.png https://healthylivingeurope.com/article/910497039-what-to-look-for-in-a-deodorant-in-canada-in-2026 Healthy Living Europe en PressRelease 2026-05-05T11:12:15+00:00 What to Look for in a Deodorant in Canada in 2026 https://ml-eu.globenewswire.com/media/MmU2ZTI3ZDAtOWNkMi00Y2Y4LWE5N2EtZWFiZTg0NGFjZTk0LTEzMjI4ODctMjAyNi0wNS0wNS1lbg==/tiny/Beiersdorf-Canada-Inc-.png https://healthylivingeurope.com/article/910497392-cellectar-biosciences-reports-positive-12-month-follow-up-data-from-phase-2b-clover-wam-study-demonstrating-durable-responses-and-efficacy-of Healthy Living Europe en PressRelease 2026-05-05T11:10:00+00:00 Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://healthylivingeurope.com/article/910497403-uniqure-announces-first-quarter-2026-financial-results-and-provides-recent-company-updates Healthy Living Europe en PressRelease 2026-05-05T11:05:00+00:00 uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates https://ml.globenewswire.com/media/2ba61fe2-12e5-4a01-afe1-419652b31512/small/logo-uniqure-ms-word-orange-jpg.jpg https://healthylivingeurope.com/article/910497470-sotera-health-delivers-strong-first-quarter-2026-results-and-reaffirms-2026-outlook Healthy Living Europe en PressRelease 2026-05-05T11:03:49+00:00 Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook https://ml.globenewswire.com/media/a0ec722c-ad65-4f05-a8ae-bc1aa6cc4db4/small/sotera-png.png